Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$92.64
$0.971.06%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.64% | 10.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.64% | 10.91% | |||
| Cost of Revenue | -5.82% | 9.96% | |||
| Gross Profit | -5.56% | 11.30% | |||
| SG&A Expenses | 7.67% | -0.31% | |||
| Depreciation & Amortization | -4.19% | 6.34% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.99% | 3.81% | |||
| Operating Income | -27.54% | 43.25% | |||
| Income Before Tax | -20.75% | 25.48% | |||
| Income Tax Expenses | -4.91% | 358.73% | |||
| Earnings from Continuing Operations | -23.98% | -3.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 14.29% | -250.00% | |||
| Net Income | -24.01% | -3.85% | |||
| EBIT | -27.54% | 43.25% | |||
| EBITDA | -18.90% | 26.71% | |||
| EPS Basic | -23.93% | -2.31% | |||
| Normalized Basic EPS | -28.91% | 42.38% | |||
| EPS Diluted | -23.70% | -3.03% | |||
| Normalized Diluted EPS | -28.91% | 42.29% | |||
| Average Basic Shares Outstanding | -0.10% | -1.58% | |||
| Average Diluted Shares Outstanding | -0.10% | -1.53% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.31% | 0.01% | |||